PulmoGate

Japan · Healthtech · AI

PulmoGate develops remote specialist review and medical AI tools for interstitial lung disease.

What PulmoGate does

PulmoGate is a Nagoya University research spinout working on interstitial lung disease. Its remote multidisciplinary review platform connects specialist expertise for second opinions.

The company is preparing broader service deployment while developing diagnostic AI, treatment-support AI and home monitoring and respiratory rehabilitation applications. The financing will support clinical validation, product development and its regulatory team.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed~¥330MBeyond Next Ventures, Inc. — LeadMitsubishi UFJ Capital Co., Ltd. — ParticipantSTATION Ai Central Japan 2-go Fund — ParticipantTeijin Pharma — Participant
Sourcespulmogate.com ↗prtimes.jp ↗